These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 18024088
1. Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up. Nickel MK, Loew TH. Eur Psychiatry; 2008 Mar; 23(2):115-7. PubMed ID: 18024088 [Abstract] [Full Text] [Related]
3. Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH. Biol Psychiatry; 2005 Mar 01; 57(5):495-9. PubMed ID: 15737664 [Abstract] [Full Text] [Related]
4. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, Fartacek R, Lahmann C, Buschmann W, Tritt K, Bachler E, Mitterlehner F, Pedrosa Gil F, Leiberich P, Rother WK, Egger C. J Clin Psychopharmacol; 2006 Feb 01; 26(1):61-6. PubMed ID: 16415708 [Abstract] [Full Text] [Related]
5. Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up. Leiberich P, Nickel MK, Tritt K, Pedrosa Gil F. J Psychopharmacol; 2008 Sep 01; 22(7):805-8. PubMed ID: 18308777 [Abstract] [Full Text] [Related]
6. Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study. Nickel C, Lahmann C, Tritt K, Muehlbacher M, Kaplan P, Kettler C, Krawczyk J, Loew TH, Rother WK, Nickel MK. J Affect Disord; 2005 Aug 01; 87(2-3):243-52. PubMed ID: 15985295 [Abstract] [Full Text] [Related]
7. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, Nickel MK. J Psychopharmacol; 2005 May 01; 19(3):287-91. PubMed ID: 15888514 [Abstract] [Full Text] [Related]
8. Topiramate treatment of aggression in male borderline patients. Nickel MK. Aust N Z J Psychiatry; 2007 May 01; 41(5):461-2. PubMed ID: 17464743 [No Abstract] [Full Text] [Related]
9. Topiramate reduced aggression in female patients with borderline personality disorder. Nickel M. Eur Arch Psychiatry Clin Neurosci; 2007 Oct 01; 257(7):432-3. PubMed ID: 17902007 [No Abstract] [Full Text] [Related]
10. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P. Am J Psychiatry; 2006 May 01; 163(5):833-8. PubMed ID: 16648324 [Abstract] [Full Text] [Related]
11. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. Frankenburg FR, Zanarini MC. J Clin Psychiatry; 2002 May 01; 63(5):442-6. PubMed ID: 12019669 [Abstract] [Full Text] [Related]
12. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. Hedges DW, Reimherr FW, Hoopes SP, Rosenthal NR, Kamin M, Karim R, Capece JA. J Clin Psychiatry; 2003 Dec 01; 64(12):1449-54. PubMed ID: 14728106 [Abstract] [Full Text] [Related]
13. Topiramate treatment of women with borderline personality disorder, part II: an open 18-month follow-up. Loew TH, Nickel MK. J Clin Psychopharmacol; 2008 Jun 01; 28(3):355-7. PubMed ID: 18480701 [No Abstract] [Full Text] [Related]
14. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study. Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P. Clin J Pain; 2006 Jun 01; 22(6):526-31. PubMed ID: 16788338 [Abstract] [Full Text] [Related]
15. Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. Nickel MK, Loew TH, Pedrosa Gil F. Psychopharmacology (Berl); 2007 May 01; 191(4):1023-6. PubMed ID: 17318503 [Abstract] [Full Text] [Related]
16. Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation. Egger C, Muehlbacher M, Schatz M, Nickel M. J Clin Psychopharmacol; 2007 Oct 01; 27(5):475-8. PubMed ID: 17873679 [Abstract] [Full Text] [Related]
17. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Am J Psychiatry; 2005 Mar 01; 162(3):621-4. PubMed ID: 15741486 [Abstract] [Full Text] [Related]
18. Topiramate for migraine prevention: a randomized controlled trial. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group. JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912 [Abstract] [Full Text] [Related]
19. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group. Headache; 2007 Feb 25; 47(2):170-80. PubMed ID: 17300356 [Abstract] [Full Text] [Related]
20. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ. J Clin Psychiatry; 2001 Mar 25; 62(3):199-203. PubMed ID: 11305707 [Abstract] [Full Text] [Related] Page: [Next] [New Search]